A 24-WEEK, MULTICENTER, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE CHANGES IN GLUCOSE METABOLISM IN PATIENTS WITH SCHIZOPHRENIA RECEIVING TREATMENT WITH OLANZAPINE, QUETIAPINE AND RISPERIDONE

OBJECTIVE: This randomized, 24-week, flexible-dose study compared changes in glucose metabolism in patients with schizophrenia receiving initial exposure to olanzapine, quetiapine, or risperidone. METHODS: The hypothesized primary endpoint was change (baseline to Week 24) in area under the curve 0-2...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Newcomer, John W., Ratner, Robert E., Eriksson, Jan W., Emsley, Robin, Meulien, Didier, Miller, Frank, Leonova-Edlund, Julia, Leong, Ronald W, Brecher, Martin
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2009
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3703648/
https://ncbi.nlm.nih.gov/pubmed/19358783
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi